healthcare
France Probes Link Between Two Baby Deaths and Milk Formula
Novo Nordisk Expands Diabetes Cell Therapy Partnership With Aspect Biosystems
Paracetamol/Tylenol in Pregnancy Is Safe, Says European Research Prompted by Trump Autism Claims
Novo's Wegovy Pill Tracks 3,071 Prescriptions in First Days of Launch
Novo's Wegovy Pill Makes Encouraging Start in Weight-Loss Race vs Lilly
Date: January 16, 2026
LONDON, Jan 16 (Reuters) - Shares of Novo Nordisk rose 7% on Friday, touching their highest level since September, and were among the top gainers in Europe, ahead of U.S. prescription data expected...
UK Health Regulator Approves Higher Dose of Novo's Wegovy for Obesity Patients
Date: January 16, 2026
Jan 16 (Reuters) - Britain's health regulator approved a maximum weekly dose of up to 7.2 milligrams of Novo Nordisk's blockbuster weight-loss drug Wegovy on Friday, to be administered as three...
Israel Sees Spike in Ptsd and Suicide Among Troops as War Persists
Date: January 16, 2026
By Emily Rose JERUSALEM, Jan 16 (Reuters) - Israel is grappling with a dramatic increase in post-traumatic stress disorder and suicide among its troops after its two-year assault on Gaza, precipitated...
London's FTSE 100 Notches New High on Mining, Healthcare Boost
Date: January 14, 2026
By Tharuniyaa . Jan 14 (Reuters) - The UK's FTSE 100 scaled a record high on Wednesday, powered by gains in mining and healthcare stocks, while education company Pearson fell after losing a New Jersey...
Russia Detains Top Doctors at Siberian Hospital After Nine Babies Die
Date: January 14, 2026
MOSCOW, Jan 14 (Reuters) - Russia has detained the chief doctor and acting head of the intensive care unit at a Siberian maternity hospital after the deaths of nine newborn babies, investigators said...
Novo Nordisk Flags Near-Term Headwinds in International Operations
Date: January 13, 2026
Jan 13 (Reuters) - Novo Nordisk CEO Mike Doustdar said on Tuesday the drugmaker expects headwinds in its international operations in 2026, as competition intensifies after losing market exclusivity in...